1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Cox proportional hazards model for the association of the presence of spotty calcium on CTA with the occurrence of the MACE composite outcome and the individual MACE components (n = 194)a
MACE (–) MACE (+) HR (95% CI) P Value MACEb (n = 38) 23 (14.7) 17 (44.7) 4.08 (2.13–7.83) <.001 Any stroke (n = 19) 32 (18.3) 8 (42.1) 3.25 (1.30–8.11) .01 Ipsilateral stroke (n = 14) 35 (19.4) 5 (35.7) 2.61 (0.87–7.82) .09 ACS (n = 16) 31 (17.4) 9 (56.3) 6.39 (2.34–17.45) <.001 Cardiovascular mortality (n = 12) 35 (19.2) 5 (41.7) 3.01 (0.95–9.48) .06 All-cause mortality (n = 32) 28 (17.3) 12 (37.5) 2.57 (1.25–5.26) .01